Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-15-049720)

Filing Details

Accession Number:: 0001209191-15-049720
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-06-03 17:28:35
Reporting Period:: 2015-06-01

Filing Date:: 2015-06-03
Accepted Time:: 2015-06-03 17:28:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1328143	Adamas Pharmaceuticals Inc	ADMS	Pharmaceutical Preparations (2834)	421560076

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1266427	M Ivan Lieberburg	C/O Adamas Pharmaceuticals, Inc. 1900 Powell St., Suite 750 Emeryville CA 94608		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-06-01	3,000	$17.93	66,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	16,000	Indirect	Ivan Lieberburg and Janice Kirsch as CPWTROS

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.